The House Appropriations Committee approved the Fiscal Year 2014 Department of Homeland Security Appropriations bill May 22, proposing an increase of $35 million over the President’s budget request, it said. The move would allow CBP to hire 1,600 additional officers, “as requested, in part, in the White House fiscal year 2014 budget,” said the National Treasury Employees Union.
A listing of recent antidumping and countervailing duty messages from the International Trade Administration posted to CBP's website May 22, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at addcvd.cbp.gov. (CBP occasionally adds backdated messages without otherwise indicating which message was added. ITT will include a message date in parentheses in such cases.)
Mexico's Diario Oficial of May 22 lists notices from the Secretary of the Economy as follows:
The International Trade Commission is publishing notices in the May 22 Federal Register on the following AD/CV injury, Section 337 patent, and other trade proceedings (any notices that warrant a more detailed summary will appear in another ITT article):
The International Trade Commission is asking for comments by May 31 on public interest factors raised by Graphics Properties Holdings’ Section 337 patent complaint on consumer electronics devices with display and processing capabilities. According to GPH, laptops, netbooks, PCs, television sets, HD camcorders, and Blu-ray and DVD players imported and sold by Panasonic, Toshiba, Vizio, AmTran, and ZTE are infringing its patents. GPH is requesting a limited exclusion order and cease and desist order preventing importation and sale of the allegedly infringing merchandise.
The Commerce Department published notices in the May 22 Federal Register on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):
Consumer Product Safety Commission announced the following voluntary recalls May 21:
The Food and Drug Administration is considering refusing admission of imports of active pharmaceutical ingredients (APIs) and finished pharmaceuticals from Boehringer-Ingelheim Pharma’s Ingelheim am Rhein, Germany facility. According to an FDA warning letter, an agency inspection found serious violations of current good manufacturing practice requirements for both types of products at the facility.
On May 21, the Foreign Agricultural Service posted the following GAIN reports:
The Bureau of Industry and Security will hold a webinar May 29 at 2:30 p.m. on certain provisions of the final rules on initial implementation of export control reform. The webinar will take the place of the normal Wednesday teleconference held by Assistant Secretary Kevin Wolf. Topics will include new provisions with respect to de minimis and the foreign direct product rule under the Export Administration Regulations, which will become effective October 15, 2013. BIS is charging $35 for the webinar. Register (here).